Meeting program

Thursday, April 24

Various satellite symposia will take place the day before the meeting for national and regional participants.

 

Friday, April 25 - EHA-Balkan Hematology Day 2025

09:15 - 10:30 CEST Opening remarks & special lecture

  • Welcome of participants
    Irina Panovska-Stavridis (North Macedonia)
  • Welcome note and introduction of meeting program
    Dimitar Efremov (Italy)
  • History of EHA Balkan Day
    Gianluca Gaidano (Italy)
  • History of Balkan Hematology Societies
    Oliver Karanfilski (North Macedonia)
  • Recent regional developments in the treatment of lymphoma
    Irina Panovska-Stavridis (North Macedonia)
  • CART program
    Speaker to be announced

10:30 - 10:45 Coffee break

10:45 - 12:15 Session 1: Mantle-cell lymphoma (Indolent and non-Hodgkin lymphoma)

  • State-of-the-Art lecture
    Georg Hess (Germany)
  • How to manage Waldenstrom's Macroglobulinemia in 2025
    Evdoxia Hatjiharissi (Greece)
  • Title to be announced
    Murat Özbalak (Türkiye)
  • Case report: Ibrutinib on North Macedonian experience
    Nevenka Ridova (North Macedonia)
  • Indolent mantle cell lymphoma
    Speaker to be announced
  • Panel discussion
    All speakers
     

12:15 - 13:15 Satellite symposium

13:15 - 14:15 Lunch break

14:15 - 15:45 Session 2: Hodgkin lymphoma

  • State-of-the-Art lecture
    Sirpa Lëppa (Finland)
  • HIV - Associated Hodgkin's lymphoma Prognosis and Therapy
    Miranda Hoti (Kosovo)
  • Title to be announced
    Hristina Ivanova (Bulgaria)
  • Title to be announced
    Ecem Yön (Türkiye)
  • Hodgkin lymphoma
    Darko Antic (Serbia)
  • Panel discussion
    All speakers

15:45 - 17:15 Session 3: Large B cell lymphomas

  • State-of-the-Art lecture
    Maria Gomes da Silva (Portugal)
  • Title to be announced
    Ivan Negara (Moldova/Italy)
  • Inflammation and inflammatory prognostic indices in Diffuse large B-cell lymphomas
    Zorica Cvetković (Serbia)
  • Prognostic significance of CD 47 expression in patients with newly diagnosed Large B cell lymphoma
    Ilija Bukurecki (Serbia)
  • What treatment for DLBCL in 2025?
    Arben Ivanaj (Albania)
  • Panel discussion
    All speakers

17:15 - 17:30 Coffee break

17:30 - 19:00 Session 4: Marginal Zone Lymphoma

  • State-of-the-Art lecture
    Speaker to be announced
  • Title to be announced
    Zdravko Mitrović (Croatia)
  • Title to be announced
    Selin Küçükyurt Kaya (Türkiye)
  • Case report 1
    Speaker to be announced
  • Case report 2
    Speaker to be announced
  • Panel discussion
    All speakers

19:00 Closing remarks

 

Saturday, April 26 - National Congress of the Macedonian Hematology Association

Program to be published shortly.